Corrigendum to “Edoxaban for Treatment of Venous Thromboembolism in Patient Groups With Different Types of Cancer: Results From the Hokusai VTE Cancer Study” [Thromb. Res. Vol. 185, January 2020, Pages 13–19]

Thrombosis Research - United Kingdom
doi 10.1016/j.thromres.2020.02.022
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Elsevier BV

Related search

Edoxaban for Treatment of Venous Thromboembolism in Patients With Cancer

Thrombosis and Haemostasis
Hematology
2015English

Design and Rationale of the Non-Interventional, Edoxaban Treatment in routiNe Clinical prActice in Patients With Venous ThromboEmbolism in Europe (ETNA-VTE-Europe) Study

Thrombosis Journal
Hematology
2018English

Anticoagulation for the Initial Treatment of Venous Thromboembolism in Patients With Cancer

Cochrane Database of Systematic Reviews
2014English

Prevention and Treatment of Venous Thromboembolism in Patients With Cancer

Therapeutic Advances in Hematology
Hematology
2011English

Prevention and Treatment of Venous Thromboembolism in Patients With Cancer

Canadian Pharmacists Journal
Pharmaceutical SciencePharmacy
2012English

Anticoagulation for the Long-Term Treatment of Venous Thromboembolism in Patients With Cancer

Cochrane Database of Systematic Reviews
2014English

Tinzaparin for Long-Term Treatment of Venous Thromboembolism in Patients With Cancer

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2017English

Patient Satisfaction With Venous Thromboembolism Treatment

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2019English

Inferior Vena Cava Filters in Patients With Cancer and Venous Thromboembolism (VTE): Patterns of Use and Outcomes

Thrombosis Research
Hematology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy